A specialist blood test in Birmingham used to monitor pancreatic and gastrointestinal cancers and track changes over time.
The CA19-9 blood test measures a tumour marker sometimes released by pancreatic and gastrointestinal cancers. It’s mainly used to monitor known disease checking treatment response or spotting recurrence. Because levels can rise for non-cancer reasons, results are always interpreted carefully, alongside symptoms, imaging and medical history.
CA19-9 is not a general screening test. Its value lies in observing trends and supporting clinical decisions over time.
Arrange a Birmingham CA19-9 blood test with clinician interpretation and clear guidance on what your result means.
Clear answers about preparation, results, limitations and how this tumour marker fits into wider medical assessment.
No. Fasting isn’t required. It’s a standard blood draw taken from a vein in your arm.
Results are usually available within 2–5 working days, with clinician review and explanation.
Many labs use around 37 U/mL as an upper reference limit, but a single raised result isn’t diagnostic.
Yes, liver disease, bile duct problems, pancreatitis and gallstones can all increase CA19-9 levels.
No, it’s not recommended for population screening and is most useful for monitoring known conditions.
WhatsApp us